Franklin Resources Inc Intercept Pharmaceuticals, Inc. Transaction History

Franklin Resources Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$9.99 - $18.71 $2,677 - $5,014	268 Added 1.46%	18,626 $345,000
Q2 2023 Aug 11, 2023	BUY	$9.17 - $19.29 $93,790 - $197,298	10,228 Added 125.81%	18,358 $203,000
Q1 2023 May 12, 2023	BUY	$12.53 - $21.71 $588 - $1,020	47 Added 0.58%	8,130 $109,000
Q4 2022 Feb 10, 2023	BUY	$11.61 - $16.11 $998 - $1,385	86 Added 1.08%	8,083 $99,000
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $1,733 - $2,797	142 Added 1.81%	7,997 $111,000
Q2 2022 Aug 11, 2022	SELL	$11.23 - $19.59 $37,564 - $65,528	-3,345 Reduced 29.87%	7,855 $108,000
Q1 2022 May 13, 2022	BUY	$13.37 - $17.79 $149,744 - $199,248	11,200 New	11,200 $182,000
Q4 2021 Feb 11, 2022	SELL	$14.28 - $19.53 $34,514 - $47,204	-2,417 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$12.99 - $20.47 $27,759 - $43,744	2,137 Added 763.21%	2,417 $36,000
Q2 2021 Aug 13, 2021	SELL	$15.46 - $24.5 $216 - $343	-14 Reduced 4.76%	280 $6,000
Q1 2021 May 13, 2021	SELL	$19.33 - $37.75 $11,172 - $21,819	-578 Reduced 66.28%	294 $7,000
Q4 2020 Feb 10, 2021	BUY	$24.48 - $42.47 $21,346 - $37,033	872 New	872 $22,000
Q4 2019 Feb 12, 2020	SELL	$57.36 - $124.1 $38.4 Million - $83.2 Million	-670,200 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $18.8 Million - $29.2 Million	241,700 Added 56.41%	670,200 $53.3 Million
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $13.3 Million - $17.5 Million	145,200 Added 51.25%	428,500 $47.9 Million
Q4 2018 Feb 12, 2019	BUY	$85.79 - $126.46 $24.3 Million - $35.8 Million	283,300 New	283,300 $28.6 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.